Journal article
Acute therapeutic intervention. Antithrombotic and antiplatelet-aggregating drugs
Neurosurgery clinics of North America, Vol.8(2), pp.207-217
04/1997
DOI: 10.1016/S1042-3680(18)30323-1
PMID: 9113702
Abstract
Although antiplatelet and anticoagulant drugs are of proven usefulness in the prevention of stroke among high-risk persons, their value in improving outcome after acute ischemic stroke has not been established. Potentially effective drugs include heparin, low molecular weight heparins and heparinoids, aspirin, and the new glycoprotein IIb/IIIa platelet receptor antagonists. Clinical trials are testing these drugs, and the role of emergent administration of anticoagulant or antiplatelet drugs in the acute treatment of persons with ischemic stroke should be clarified in the near future.
Details
- Title: Subtitle
- Acute therapeutic intervention. Antithrombotic and antiplatelet-aggregating drugs
- Creators
- Harold P Adams Jr - Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USAEnrique C Leira
- Resource Type
- Journal article
- Publication Details
- Neurosurgery clinics of North America, Vol.8(2), pp.207-217
- Publisher
- United States
- DOI
- 10.1016/S1042-3680(18)30323-1
- PMID
- 9113702
- ISSN
- 1042-3680
- eISSN
- 1558-1349
- Language
- English
- Date published
- 04/1997
- Academic Unit
- Neurology; Epidemiology; Iowa Neuroscience Institute; Neurosurgery
- Record Identifier
- 9984020724302771
Metrics
29 Record Views